Issue Cover

Oncology

Interesting articles on oncology, including new treatments, screening measures, and new pharmaceutical innovations.

Articles

article-item
The AI frontier: transforming immunotherapy with intelligent drug discovery

Vicky Qu at BioMap considers the use of artificial intelligence in immuno-oncology and how its use can improve conventional drug discover y processes

1 October 2023Oncology
article-item
Repairing not destroying: the future of targeted cancer drug design

Lukasz Jaremko from King Abdullah University of Science and Technology, Saudi Arabia explains how using nuclear magnetic resonance to study the dynamics of epigenetic targets may enable drug development that does not kill but resets cancer cells to a benign state

1 October 2023Oncology
article-item
To achieve diversity in clinical trials, patient-led drug development is key

Amy McKee from Parexel considers the need for diversity in oncology clinical trials in order to fully realise the potential of personalised medicine

1 October 2023Oncology
article-item
The changing treatment landscape for follicular lymphoma

Dr Mitchell Smith and Dr Julie Dodds tell Pharmafile about recent R&D in the field of blood cancers including follicular lymphoma

1 October 2023Oncology
article-item
Prostate cancer: new screening measures and decreasing mortality rates

Professor Hendrik van Poppel talks to Pharmafile about new campaigns to improve prostate cancer screening, the current standard-of-care treatments and what obstacles still need to be addressed in treatment

1 October 2023Oncology
article-item
A targeted approach to developing targeted blood cancer therapies

Precision medicine and targetted solutions can be utilised to treat cancer, but how can this develop in the future?

31 May 2022Oncology
article-item
Supporting the challenges of innovative systemic treatments

How can the benefits of immunotherapy be maximised for each patient?

31 May 2022Oncology
article-item
NHS waiting lists: the second healthcare crisis?

Novartis UK tells Pharmafile how COVID-19 impacted patient access to oncology treatments, and how the pharma industry can support the NHS

31 May 2022Oncology
article-item
Embrace disruption: the changing landscape of clinical research

How can precision medicine and personalised treatments improve healthcare in Europe and worldwide?

31 May 2022Oncology
article-item
New treatments and new challenges: The oncology constant is change

The UK has seen many innovations in the healthcare sphere, many have which have been in oncology, but what are the next steps in this ever-evolving field?

31 May 2022Oncology
article-item
Novel targets are the future of solid tumour immunotherapy

Pharmafile speaks to Enara Bio: Enara Bio tell Pharmafile about the unmet patient needs in oncology, and how these can be tackled by novel therapies, as well as considering the future of immunotherapy

31 May 2022Oncology